A preclinical toxicology and pharmacology study of OQL051, a gut-restricted CDK4/6 inhibitor for the prophylaxis of chemotherapy-induced diarrhea. (October 2022) - Zeng, W.; Li, W.; Liu, S.; Chen, L.; Tyler, R.; Tang, H.; Luo, J.; Zhang, S.